How Big Is the GBM Market | Forecast, Trends & Segmentation 2031

Q: How big is the GBM market?

The GBM market was estimated at USD 2.2 billion in 2024 and is projected to reach USD 6.1 billion by 2031

Q: What factors are driving the GBM market?

Key drivers include rising cases, targeted therapy development, and innovation in neuro-oncology research

Q: Who are the top companies in the GBM market?

Leading players include Roche, Merck, Novocure, Pfizer, and Bristol Myers Squibb

Q: What are some recent trends in the market?

Trends include AI-assisted diagnosis, CAR-T cell therapy, personalized vaccines, and genomic profiling

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6116

Publication Date: Jul 2025

What is the size of the GBM Market?

According to 6Wresearch internal database and industry insights, the Glioblastoma Multiforme (GBM) Market was estimated at USD 2.2 billion in 2024 and is projected to reach USD 6.1 billion by 2031, growing at a CAGR of 6.3% during the forecast period 2025–2031.

Due to increasing incidence of brain tumours, advancements in targeted therapies, and rising investments in oncology research, the GBM market is expected to rise in the forthcoming years.

Key Growth Drivers of the GBM Market

Rising prevalence of high-grade brain tumours globally
Introduction of targeted therapies and immunotherapies
Increasing clinical trials and R&D for novel drug candidates
Improved access to neuro-oncology diagnostics and treatments
Government and private funding in brain cancer research

GBM Market Trends

GBM market is growing over the years with notable trends such as adoption of precision medicine and genomic profiling is growing. Further, the combination therapies are being tested to improve survival outcomes. With the time, AI is being used for imaging analysis and early diagnosis. Other trends such as tumour-treating fields and personalized vaccines are emerging as supportive therapies. All these trends are contributing in the expansion of the market dynamics.

Emerging Developments in the GBM Market

GBM market is seeing few developments in the recent years as the CAR-T cell therapies and oncolytic virus platforms are under active investigation. Further, the blood-brain barrier penetration technologies are improving drug delivery. Aside from these, the new molecules targeting glioma stem cells and resistance mechanisms are entering clinical pipelines, promising more effective treatment options. These developments are making the bigger presence of the market.